EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Akkermansia muciniphila improves chronic colitis‐induced enteric neuroinflammation in mice

Ozgur Yilmaz, Sinem Oktem Okullu, Merve Catakci, Merve Acikel Elmas, Yuri Pinheiro, Serap Arbak, Ekin Demir iD, Karl Herbert Schaefer, Meltem Kolgazi

Neurogastroenterology & Motility · 2024-03 · 36 (3)

DOI: 10.1111/nmo.14745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 23.01.2024. Verfasst von Ozgur Yilmaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel diseases (IBD) are chronic diseases that are not fully understood. Drugs in use can only be applied for a short time due to their side effects. Therefore, research is needed to develop new treatment approaches. In addition, it has been proven that IBD causes degeneration in the enteric nervous system (ENS). In recent years, it has been discussed that probiotics may have positive effects in the prevention and treatment of inflammatory enteric degeneration. Akkermansia muciniphila ( A. muciniphila ) is an anaerobic bacterium found in the mucin layer of the intestinal microbiota. It has been found that the population of A. muciniphila decreases in the case of different diseases. In light of this information, the curative effect of A. muciniphila application on colitis‐induced inflammation and enteric degeneration was investigated.

Methods

In this study, 5 weeks of A. muciniphila treatment in Trinitro‐benzene‐sulfonic acid (TNBS)–induced chronic colitis model was investigated. Colon samples were examined at microscopic, biochemical, and molecular levels. Fecal samples were collected before, during, and after treatment to evaluate the population changes in the microbiota. Specific proteins secreted from the ENS were evaluated, and enteric degeneration was examined.

Results

As a result of the research, the ameliorative effects of A. muciniphila were shown in the TNBS colitis model‐induced inflammation and ENS damage.

Discussion

In light of these results, A. muciniphila can potentially be evaluated as a microbiome‐based treatment for IBD with further clinical and experimental studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInflammatory Bowel DiseasesMiceAnimalsNeuroinflammatory DiseasesBase CompositionSequence Analysis, DNARNA, Ribosomal, 16SPhylogenyVerrucomicrobiaInflammationChronic DiseaseAkkermansia

Stichwörter der Autor:innen

Akkermansia muciniphilachronic diseasesenteric nervous systemgut healthinflammatory bowel diseases

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Physiology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Department of Microbiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Department of Histology and Embryology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Research Unit of Comparative Microbiome Analysis, Helmholtz Zentrum Muenchen, Munich, Germany.
  • Department of Surgery, School of Medicine Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Research and Transfer Working Group Enteric Nervous System (AGENS), University of Applied Sciences Kaiserslautern, Zweibrücken, Germany.

ORCID-Profile: Ekin Demir

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Yilmaz, O., Okullu, S. O., Catakci, M., Elmas, M. A., Pinheiro, Y., Arbak, S., Demir, E., Schaefer, K. H., & Kolgazi, M. (2024). Akkermansia muciniphila improves chronic colitis‐induced enteric neuroinflammation in mice. Neurogastroenterology & Motility, 36(3). https://doi.org/10.1111/nmo.14745

Vancouver

Yilmaz O, Okullu SO, Catakci M, Elmas MA, Pinheiro Y, Arbak S, et al. Akkermansia muciniphila improves chronic colitis‐induced enteric neuroinflammation in mice. Neurogastroenterology & Motility. 2024;36(3). doi:10.1111/nmo.14745

BibTeX
@article{Yilmaz2024,
  author = {Yilmaz, Ozgur and Okullu, Sinem Oktem and Catakci, Merve and Elmas, Merve Acikel and Pinheiro, Yuri and Arbak, Serap and Demir, Ekin and Schaefer, Karl Herbert and Kolgazi, Meltem},
  title = {Akkermansia muciniphila improves chronic colitis‐induced enteric neuroinflammation in mice},
  journal = {Neurogastroenterology & Motility},
  year = {2024},
  volume = {36},
  number = {3},
  doi = {10.1111/nmo.14745}
}
Kostenlos starten →